Business Description
Onward Medical NV
NAICS : 325414
SIC : 8731
ISIN : NL0015000HT4
Total Employee Number:
122Compare
Compare
Traded in other countries / regions
ONWD.BelgiumONWRF.USA63E.GermanyONWDb.UK IPO Date
2022-02-17Description
Onward Medical NV is developing and commercializing therapies to enable functional recovery for people with Spinal Cord Injury (SCI). The company's technology platforms are based on ONWARD ARC Therapy (ARC Therapy), targeted, programmed electrical stimulation of the spinal cord designed to restore movement, independence, and health in people with SCI.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 4.98 | |||||
Equity-to-Asset | 0.65 | |||||
Debt-to-Equity | 0.25 | |||||
Debt-to-EBITDA | -0.36 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | -0.51 | |||||
Beneish M-Score | 10.61 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 200 | |||||
3-Year EBITDA Growth Rate | 7.9 | |||||
3-Year EPS without NRI Growth Rate | 6.2 | |||||
3-Year FCF Growth Rate | 2 | |||||
3-Year Book Growth Rate | -17.3 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 17.57 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 148.4 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 39.94 | |||||
9-Day RSI | 41.07 | |||||
14-Day RSI | 40.28 | |||||
3-1 Month Momentum % | -10.81 | |||||
6-1 Month Momentum % | -40.54 | |||||
12-1 Month Momentum % | -27.47 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 6.67 | |||||
Quick Ratio | 6.6 | |||||
Cash Ratio | 6.14 | |||||
Days Inventory | 154.34 | |||||
Days Sales Outstanding | 65.42 | |||||
Days Payable | 764.9 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -22.9 | |||||
Shareholder Yield % | -26.89 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 72.51 | |||||
Operating Margin % | -1082.43 | |||||
Net Margin % | -1105.48 | |||||
EBITDA Margin % | -1000.34 | |||||
FCF Margin % | -1041.65 | |||||
OCF Margin % | -1030.26 | |||||
ROE % | -95.63 | |||||
ROA % | -57.74 | |||||
ROIC % | -301.51 | |||||
3-Year ROIIC % | 661.5 | |||||
ROC (Joel Greenblatt) % | -3023.88 | |||||
ROCE % | -63.24 | |||||
Moat Score | 3 | |||||
Tariff Resilience Score | 6 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 33.42 | |||||
PB Ratio | 2.67 | |||||
Price-to-Tangible-Book | 3.18 | |||||
EV-to-EBIT | -3.29 | |||||
EV-to-EBITDA | -3.41 | |||||
EV-to-Revenue | 34.16 | |||||
EV-to-FCF | -3.27 | |||||
Price-to-GF-Value | 0.02 | |||||
| Price-to-Net-Current-Asset-Value | 3.29 | |||||
| Price-to-Net-Cash | 3.84 | |||||
Earnings Yield (Greenblatt) % | -30.4 | |||||
FCF Yield % | -21.52 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:ONWRF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Onward Medical NV Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 4.408 | ||
| EPS (TTM) ($) | -1.046 | ||
| Beta | 0.8741 | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 61.67 | ||
| 14-Day RSI | 40.28 | ||
| 14-Day ATR ($) | 0.075664 | ||
| 20-Day SMA ($) | 3.1055 | ||
| 12-1 Month Momentum % | -27.47 | ||
| 52-Week Range ($) | 2.76 - 6.37 | ||
| Shares Outstanding (Mil) | 69.53 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Onward Medical NV Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Onward Medical NV Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Onward Medical NV Frequently Asked Questions
What is Onward Medical NV(ONWRF)'s stock price today?
The current price of ONWRF is $2.96. The 52 week high of ONWRF is $6.37 and 52 week low is $2.76.
When is next earnings date of Onward Medical NV(ONWRF)?
The next earnings date of Onward Medical NV(ONWRF) is .
Does Onward Medical NV(ONWRF) pay dividends? If so, how much?
Onward Medical NV(ONWRF) does not pay dividend.
Guru Commentaries on OTCPK:ONWRF
No articles.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Onward Medical NV
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers